Vor Bio Appoints Erez Kalir to Board of Directors Following PIPE Financing

VOR
September 18, 2025
Vor Bio announced on January 8, 2025, the appointment of Mr. Erez Kalir to its Board of Directors. This appointment fills a new seat created in connection with the recent private investment in public equity (PIPE) financing, which was led by Reid Hoffman. Mr. Kalir will serve as the director designee of Reprogrammed Interchange, LLC, Mr. Hoffman’s investment fund, bringing a wealth of experience as an investor, entrepreneur, and thought leader with a deep focus on life sciences and technology. His expertise is expected to be invaluable as Vor Bio continues to execute its vision. Currently, Mr. Kalir is the Managing Member of Martial Eagle Fund and a Venture Partner at FJ Labs. His background includes advising on biotech and healthcare investments at Tiger Management and co-founding Sabretooth Capital, a hedge fund. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.